FDA grants a Breakthrough Device Designation for Spiderwort Spinal Cord Technology

· by · in Biotechnology industry, iPS Cells, Personalized Therapies, Regenerative Medicine. ·


CelluBridge designated Breakthrough Device by U.S. Food and Drug Administration (FDA)
https://www.globenewswire.com/news-release/2020/11/12/2125460/0/en/FDA-grants-a-Breakthrough-Device-Designation-for-Spiderwort-Spinal-Cord-Technology.html

Leave a Reply

Fill in your details below or click an icon to log in:

Gravatar
WordPress.com Logo

You are commenting using your WordPress.com account. ( Log Out /  Change )

Google photo

You are commenting using your Google account. ( Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. ( Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. ( Log Out /  Change )

Cancel

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.